Índice

• • ·A better pathway to approval of 21st century cures?

    Página :117

     
• • ·Enterobacteriaceae: joining the dots with pan-European epidemiology

    Página :118-119

    Edward J Feil

    
• • ·New genetic marker for piperaquine resistance in Plasmodium falciparum

    Página :119-121

    Arjen M Dondorp

     
• • ·Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?

    Página :121-122

    Quique Bassat, Clara Menéndez

     
• • ·Clostridium difficile infection: stewardship’s lowest hanging fruit?

    Página :123-124

    Christopher J Graber

    
• • ·Route of transmission of Staphylococcus aureus

    Página :124-125

    Olivier Denis

     
• • ·Cutting out the roots of acute hepatitis C

    Página :125-127

    Audrey Coilly, Didier Samuel

     
• • ·Time to review treatment of isoniazid-resistant tuberculosis?

    Página :127-128

    Lia D’Ambrosio, Giovanni B Migliori, Giovanni Sotgiu

     
• • ·When free is not fair: the case of vaccine donations

    Página :128-130

    James Smith

    
• • ·How long until routine Helicobacter pylori antimicrobial susceptibility testing?

    Página :130-131

    Milagrosa Montes, Emilio Pérez-Trallero

    
• • ·HCV prevalence during the age range of peak sexual activity

    Página :131-132

    Jiman He, Jianhua Lin

    
• • ·Corrections

    Página :132

    
• • ·Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia

    Página :133-134

    Monica M Lahra, Alison Ward, Ella Trembizki, Jamie Hermanson, Emma Clements, Andrew Lawrence, David Whiley

     
• • ·Unwarranted prescription variations for treatment of latent tuberculosis infection

    Página :134

    Claudia C Dobler

    
• • ·Patients with tuberculosis in the private sector: counting the uncounted

    Página :134-135

    Gyanshankar P Mishra, Jasmin Mulani

    
• • ·Challenges to eliminate rabies virus infection in China by 2020

    Página :135-136

    Ye Chen, Jin Tian, Ji-Long Chen

      
• • ·Polio and cross-border management

    Página :136

    Muhammad Umair Khan, Akram Ahmad, Rajesh Balkrishnan

    
• • ·Availability and affordability of life-saving vaccines

    Página :136-137

    Muhammad Umair Khan, Akram Ahmad

    
• • ·The need to focus China’s national plan to combat antimicrobial resistance

    Página :137-138

    Shristi Raut, Bipin Adhikari

    
• • ·Carriage of ?-lactamase-producing Enterobacteriaceae by Chinese travellers

    Página :138-139

    Lan-Lan Zhong, Nicole Stoesser, Yohei Doi, Cong Shen, Xi Huang, Guo-Bao Tian

     
• • ·Catheter-related bloodstream infections in patients with oncohaematological malignancies

    Página :139-140

    Francisco Carmona-Torre, Jose R Yuste, Sandra Castejon, Ana Ramos, Jose L Del Pozo

    
• • ·Detection of the invasive mosquito species Aedes albopictus in southern England

    Página :140

    Jolyon M Medlock, Alexander GC Vaux, Benjamin Cull, Francis Schaffner, Emma Gillingham, Valentin Pfluger, Steve Leach

    
• • ·The challenge of imported malaria to eliminating countries

    Página :141

    Yaobao Liu, Hugh J W Sturrock, Haitao Yang, Roly D Gosling, Jun Cao

    
• • ·Underestimate of annual malaria imports to Canada

    Página :141-142

    Andrea K Boggild, Anne E McCarthy, Michael D Libman, David O Freedman, Kevin C Kain

    
• • ·Underestimate of annual malaria imports to Canada – Author reply

    Página :142-143

    Andrew J Tatem

     
• • ·Leishmaniasis unleashed in Syria

    Página :144-145

    Talha Burki

     
• • ·Highlights from the annual ASTMH meeting

    Página :146

    Marco De Ambrogi

    Esquema Esquema
• • ·Updates in tuberculosis diagnosis in the USA

    Página :147-148

    Ammara Mushtaq

     
• • ·Infectious disease surveillance update

    Página :148

    Ruth Zwizwai

    Esquema Esquema
• • ·Research brief

    Página :149

    Dara Mohammadi

    Esquema Esquema  
• • ·Lynn Morris: the continuing quest for an HIV vaccine

    Página :150

    Tony Kirby

     
• • ·Confined by consumption

    Página :151

    Mohsin Ali

     
• • ·Preparing for pandemics: no time to lose

    Página :152

    Clare Sansom

     
• • ·Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

    Página :153-163

    Hajo Grundmann, Corinna Glasner, Barbara Albiger, David M Aanensen, Chris T Tomlinson, Arjana Tambi? Andrasevi?, Rafael Cantón, Yehuda Carmeli, Alexander W Friedrich, Christian G Giske, Youri Glupczynski, Marek Gniadkowski, David M Livermore, Patrice Nordmann, Laurent Poirel, Gian M Rossolini, Harald Seifert, Alkiviadis Vatopoulos, Timothy Walsh, Neil Woodford, Dominique L Monnet

    Resumen Resumen Esquema Esquema   
• • ·Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study

    Página :164-173

    Roberto Amato, Pharath Lim, Olivo Miotto, Chanaki Amaratunga, Dalin Dek, Richard D Pearson, Jacob Almagro-Garcia, Aaron T Neal, Sokunthea Sreng, Seila Suon, Eleanor Drury, Dushyanth Jyothi, Jim Stalker, Dominic P Kwiatkowski, Rick M Fairhurst

    Resumen Resumen Esquema Esquema   
• • ·A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study

    Página :174-183

    Benoit Witkowski, Valentine Duru, Nimol Khim, Leila S Ross, Benjamin Saintpierre, Johann Beghain, Sophy Chy, Saorin Kim, Sopheakvatey Ke, Nimol Kloeung, Rotha Eam, Chanra Khean, Malen Ken, Kaknika Loch, Anthony Bouillon, Anais Domergue, Laurence Ma, Christiane Bouchier, Rithea Leang, Rekol Huy, Grégory Nuel, Jean-Christophe Barale, Eric Legrand, Pascal Ringwald, David A Fidock, Odile Mercereau-Puijalon, Frédéric Ariey, Didier Ménard

    Resumen Resumen Esquema Esquema   
• • ·Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis

    Página :184-193

    Julie Gutman, Stephanie Kovacs, Grant Dorsey, Andy Stergachis, Feiko O ter Kuile

    Resumen Resumen Esquema Esquema   
• • ·Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis

    Página :194-206

    Timothy Lawes, José-María Lopez-Lozano, Cesar A Nebot, Gillian Macartney, Rashmi Subbarao-Sharma, Karen D Wares, Carolyn Sinclair, Ian M Gould

    Resumen Resumen Esquema Esquema   
• • ·Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing

    Página :207-214

    James R Price, Kevin Cole, Andrew Bexley, Vasiliki Kostiou, David W Eyre, Tanya Golubchik, Daniel J Wilson, Derrick W Crook, A Sarah Walker, Timothy E A Peto, Martin J Llewelyn, John Paul, Modernising Medical Microbiology informatics group †

    Resumen Resumen Esquema Esquema   
• • ·Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

    Página :215-222

    Katja Deterding, Christoph D Spinner, Eckart Schott, Tania M Welzel, Guido Gerken, Hartwig Klinker, Ulrich Spengler, Johannes Wiegand, Julian Schulze zur Wiesch, Anita Pathil, Markus Cornberg, Andreas Umgelter, Caroline Zöllner, Stefan Zeuzem, Armin Papkalla, Kristina Weber, Svenja Hardtke, Heiko von der Leyen, Armin Koch, Dorothee von Witzendorff, Michael P Manns, Heiner Wedemeyer, HepNet Acute HCV IV Study Group †

    Resumen Resumen Esquema Esquema   
• • ·Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis

    Página :223-234

    Medea Gegia, Nicholas Winters, Andrea Benedetti, Dick van Soolingen, Dick Menzies

    Resumen Resumen Esquema Esquema   
• • ·Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections

    Página :e30

    Usama Ramadan Abdelmohsen, Srikkanth Balasubramanian, Tobias A Oelschlaeger, Tanja Grkovic, Ngoc B Pham, Ronald J Quinn, Ute Hentschel

    Resumen Resumen Esquema Esquema   
• • ·Human schistosomiasis in the post mass drug administration era

    Página :e42

    Francisca Mutapi, Rick Maizels, Alan Fenwick, Mark Woolhouse

    Resumen Resumen Esquema Esquema  
• • ·Photoantimicrobials—are we afraid of the light?

    Página :e49

    Mark Wainwright, Tim Maisch, Santi Nonell, Kristjan Plaetzer, Adelaide Almeida, George P Tegos, Michael R Hamblin

    Resumen Resumen Esquema Esquema  
• • ·A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

    Página :e56

    Debra A Goff, Ravina Kullar, Ellie J C Goldstein, Mark Gilchrist, Dilip Nathwani, Allen C Cheng, Kelly A Cairns, Kevin Escandón-Vargas, Maria Virginia Villegas, Adrian Brink, Dena van den Bergh, Marc Mendelson

    Resumen Resumen Esquema Esquema
• • ·A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now

    Página :e64

    Nathan C Lo, David G Addiss, Peter J Hotez, Charles H King, J Russell Stothard, Darin S Evans, Daniel G Colley, William Lin, Jean T Coulibaly, Amaya L Bustinduy, Giovanna Raso, Eran Bendavid, Isaac I Bogoch, Alan Fenwick, Lorenzo Savioli, David Molyneux, Jürg Utzinger, Jason R Andrews

    Resumen Resumen Esquema Esquema  
• • ·Pseudo-onychomycosis

    Página :235

    Mitsuhito Ota

     
• • ·Fatal infection caused by Capnocytophaga canimorsus

    Página :236

    Hélène Taquin, Christophe Roussel, Laurent Roudière, Alain Besancon, Thomas Hubiche, Michel Kaidomar, Sophie Edouard, Pascal Del Giudice